Concepedia

Steve Sugarman

SS

3

Publications

238

Citations

3

H-Index

1995

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Steve Sugarman is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cancer therapeutics, and pharmacology.

Top concepts

MedicineOncologyPharmacologyCancer TherapyPathologyImmunologyBreast CancerImmunotherapyCancer ResearchPharmacotherapy

Publications per year

1995–2008

3

Publications

3

Phase I Trial of the Anti–Lewis Y Drug Immunoconjugate BR96-Doxorubicin in Patients With Lewis Y–Expressing Epithelial Tumors

Mansoor N. Saleh, Steve Sugarman, James H. Murray et al. · Journal of Clinical Oncology · 2000 · 194 citations

Pilot Phase II Trial of 13-cis-Retinoic Acid and Interferon-α Combination Therapy for Advanced Pancreatic Adenocarcinoma

Dennis F. Moore, Richard Pazdur, Steve Sugarman et al. · American Journal of Clinical Oncology · 1995 · 30 citations

Interferon-α Combination Therapy, Retinoid-ifn Combinations, Immunology +17

Prolonged Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel in Breast Cancer Is Feasible

Chau T. Dang, Gabriella D’Andrea, Diana Lake et al. · Clinical Breast Cancer · 2008 · 14 citations

Breast Oncology, Oncology, Cyclophosphamide Followed +8

Rows per page

1–3 of 3